In 2001, approximately 135,400 Americans are expected to develop colorectal cancer, and 56,700 individuals will die from the disease. Though 80% of patients present at a stage when all apparent diseased tissue can be surgically resected, up to 40% of these patients will suffer from recurrence. Depth of tumor invasion and nodal status are considered the most important predictors of recurrence, and are the primary factors used by clinicians in recommending to patients adjuvant therapy after surgery. However, there is considerable variation in the outcome of patients with colorectal cancer not explained by traditional prognostic factors. The candidate for this award will utilize databases from two large, randomized adjuvant therapy trials to study other prognostic factors on outcomes in colon and rectal cancer. Specifically, these databases provide an opportunity to study the influence of potential modifiable treatment and patient characteristics on short- and long-term outcomes in patients with potentially curable colon and rectal cancers treated with surgery and adjuvant therapy.
The specific aims of this proposal are (1) to examine whether hospital surgical volume and hospital characteristics affect cancer recurrence, overall survival, and treatment-related toxicity in patients undergoing curative surgery and adjuvant therapy for stages II and III rectal cancer, and (2) to examine the impact of diet and lifestyle on colon cancer recurrence and survival. Completion of these projects will improve our understanding of how potentially modifiable factors affect outcomes in patients treated with curative surgery and standard adjuvant therapy. These projects will provide insight into dietary and lifestyle behaviors of patients with colon cancer and which behaviors impact outcomes. Finally, these projects will allow the candidate to gain invaluable experience in database analysis and clinical epidemiologic and health outcomes research. The candidate will complete a Masters in Public Health (MPH) degree and advanced courses at the Harvard School of Public Health during the first two years of the proposed award. The projects will be performed under the mentorship of Dr. Charles Fuchs, a well-established researcher in prevention and health services research. At the completion of the project, the candidate will have gained the experience to become an independent researcher in clinical epidemiologic and health outcomes research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic/Teacher Award (ATA) (K07)
Project #
1K07CA097992-01A1
Application #
6678510
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
2003-08-01
Project End
2008-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
1
Fiscal Year
2003
Total Cost
$135,706
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Bose, Kakoli; Meinke, Gretchen; Bohm, Andrew et al. (2011) Design and characterization of an enhanced repressor of human papillomavirus E2 protein. FASEB J 25:2354-61
Ogino, Shuji; Shima, Kaori; Nosho, Katsuhiko et al. (2009) A cohort study of p27 localization in colon cancer, body mass index, and patient survival. Cancer Epidemiol Biomarkers Prev 18:1849-58
Meyerhardt, Jeffrey A; Ogino, Shuji; Kirkner, Gregory J et al. (2009) Interaction of molecular markers and physical activity on mortality in patients with colon cancer. Clin Cancer Res 15:5931-6
Ogino, Shuji; Nosho, Katsuhiko; Irahara, Natsumi et al. (2009) Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. J Clin Oncol 27:4591-8
Ogino, Shuji; Nosho, Katsuhiko; Irahara, Natsumi et al. (2009) A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases. Clin Cancer Res 15:4431-8
Ogino, Shuji; Nosho, Katsuhiko; Shima, Kaori et al. (2009) p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis. Cancer Epidemiol Biomarkers Prev 18:2513-21
Baba, Yoshifumi; Nosho, Katsuhiko; Shima, Kaori et al. (2009) Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res 15:4665-73
Meyerhardt, Jeffrey A; Niedzwiecki, Donna; Hollis, Donna et al. (2008) Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26:4109-15
Meyerhardt, Jeffrey A; Niedzwiecki, Donna; Hollis, Donna et al. (2007) Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 298:754-64
Meyerhardt, Jeffrey A; Heseltine, Denise; Ogino, Shuji et al. (2006) Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer. Clin Colorectal Cancer 6:59-65

Showing the most recent 10 out of 19 publications